These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 9087176)

  • 1. Changes in telomerase activity and telomere length during human T lymphocyte senescence.
    Pan C; Xue BH; Ellis TM; Peace DJ; Díaz MO
    Exp Cell Res; 1997 Mar; 231(2):346-53. PubMed ID: 9087176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple pathways to cellular senescence: role of telomerase repressors.
    Oshimura M; Barrett JC
    Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere uncapping during in vitro T-lymphocyte senescence.
    Chebel A; Bauwens S; Gerland LM; Belleville A; Urbanowicz I; de Climens AR; Tourneur Y; Chien WW; Catallo R; Salles G; Gilson E; Ffrench M
    Aging Cell; 2009 Feb; 8(1):52-64. PubMed ID: 19077045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length dynamics in telomerase-positive immortal human cell populations.
    Bryan TM; Englezou A; Dunham MA; Reddel RR
    Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere end-replication problem and cell aging.
    Levy MZ; Allsopp RC; Futcher AB; Greider CW; Harley CB
    J Mol Biol; 1992 Jun; 225(4):951-60. PubMed ID: 1613801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.
    Ohmura H; Tahara H; Suzuki M; Ide T; Shimizu M; Yoshida MA; Tahara E; Shay JW; Barrett JC; Oshimura M
    Jpn J Cancer Res; 1995 Oct; 86(10):899-904. PubMed ID: 7493906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of telomeres and telomerase in cell life span.
    Counter CM
    Mutat Res; 1996 Oct; 366(1):45-63. PubMed ID: 8921986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of telomerase induction during T cell activation.
    Bodnar AG; Kim NW; Effros RB; Chiu CP
    Exp Cell Res; 1996 Oct; 228(1):58-64. PubMed ID: 8892971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities.
    Tsutsui T; Kumakura S; Tamura Y; Tsutsui TW; Sekiguchi M; Higuchi T; Barrett JC
    Carcinogenesis; 2003 May; 24(5):953-65. PubMed ID: 12771041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of telomere length in thyroid adenomas without telomerase activity.
    De Deken X; Vilain C; Van Sande J; Dumont JE; Miot F
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4368-72. PubMed ID: 9851779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length homeostasis.
    Hug N; Lingner J
    Chromosoma; 2006 Dec; 115(6):413-25. PubMed ID: 16741708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.
    Barsov EV
    Immunotherapy; 2011 Mar; 3(3):407-21. PubMed ID: 21395382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of retinoblastoma in the absence of telomerase activity.
    Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
    J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
    Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
    Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length maintenance in aging and carcinogenesis.
    Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
    Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of telomeres and telomerase.
    Fajkus J; Dvorácková M; Sýkorová E
    Methods Mol Biol; 2008; 463():267-96. PubMed ID: 18951173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.